These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers. Tateishi R, Shiina S, Yoshida H, Teratani T, Obi S, Yamashiki N, Yoshida H, Akamatsu M, Kawabe T, Omata M. Hepatology; 2006 Dec; 44(6):1518-27. PubMed ID: 17133456 [Abstract] [Full Text] [Related]
23. A new tumor-associated antigen useful for serodiagnosis of hepatocellular carcinoma, defined by monoclonal antibody KM-2. Kumagai Y, Chiba J, Sata T, Ohtaki S, Mitamura K. Cancer Res; 1992 Sep 15; 52(18):4987-94. PubMed ID: 1381274 [Abstract] [Full Text] [Related]
24. [Hepatocellular carcinoma]. Lemoine A, Azoulay D, Jezequel-Cuer M, Debuire B. Pathol Biol (Paris); 1999 Nov 15; 47(9):903-10. PubMed ID: 10609270 [Abstract] [Full Text] [Related]
25. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin. Li Y, Yu DC, Chen Y, Amin P, Zhang H, Nguyen N, Henderson DR. Cancer Res; 2001 Sep 01; 61(17):6428-36. PubMed ID: 11522637 [Abstract] [Full Text] [Related]
26. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. Gambarin-Gelwan M, Wolf DC, Shapiro R, Schwartz ME, Min AD. Am J Gastroenterol; 2000 Jun 01; 95(6):1535-8. PubMed ID: 10894592 [Abstract] [Full Text] [Related]
27. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. Soresi M, Magliarisi C, Campagna P, Leto G, Bonfissuto G, Riili A, Carroccio A, Sesti R, Tripi S, Montalto G. Anticancer Res; 2003 Jun 01; 23(2C):1747-53. PubMed ID: 12820452 [Abstract] [Full Text] [Related]
28. Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma. Beneduce L, Castaldi F, Marino M, Quarta S, Ruvoletto M, Benvegnù L, Calabrese F, Gatta A, Pontisso P, Fassina G. Cancer; 2005 Jun 15; 103(12):2558-65. PubMed ID: 15887222 [Abstract] [Full Text] [Related]
29. [Diagnosis of hepatocellular carcinoma using chicken anti-monoclonal antibody--as tumor marker on the heterophilic hanganutziu-deicher antigen]. Koda T, Shimosakoda T, Nishinaka S, Asaoka H, Nakaba H, Tamura I, Matsuda H. Gan To Kagaku Ryoho; 1994 Dec 15; 21(16):2771-7. PubMed ID: 7993113 [Abstract] [Full Text] [Related]
30. Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy. Kudo M. Oncology; 2008 Dec 15; 75 Suppl 1():1-12. PubMed ID: 19092266 [Abstract] [Full Text] [Related]
31. The characteristics of hepatocellular carcinoma with a high level of serum lactic dehydrogenase: a case report. Fujiwara Y, Takenaka K, Kajiyama K, Maeda T, Gion T, Shirabe K, Shimada M, Sugimachi K. Hepatogastroenterology; 1997 Dec 15; 44(15):820-3. PubMed ID: 9222698 [Abstract] [Full Text] [Related]
32. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients. Cedrone A, Covino M, Caturelli E, Pompili M, Lorenzelli G, Villani MR, Valle D, Sperandeo M, Rapaccini GL, Gasbarrini G. Hepatogastroenterology; 2000 Dec 15; 47(36):1654-8. PubMed ID: 11149026 [Abstract] [Full Text] [Related]
33. [Detection of alpha-fetoprotein-L3 using agglutinin-coupled spin column to be used in diagnosis of hepatocellular carcinoma]. Sun GZ, Zhao XY, Li JH, Zhao GQ, Wang SX, Kong SL. Zhonghua Yi Xue Za Zhi; 2008 Jul 22; 88(28):1986-8. PubMed ID: 19062741 [Abstract] [Full Text] [Related]
34. Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma. Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Takasaki K, Takenami K, Yamamoto M, Nakano M. Cancer; 2000 Feb 01; 88(3):544-9. PubMed ID: 10649245 [Abstract] [Full Text] [Related]
35. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma. Hsia CY, Huo TI, Chiang SY, Lu MF, Sun CL, Wu JC, Lee PC, Chi CW, Lui WY, Lee SD. Eur J Surg Oncol; 2007 Mar 01; 33(2):208-12. PubMed ID: 17140760 [Abstract] [Full Text] [Related]
36. Serum ferritin in hepatocellular carcinoma. Zhou XD, Stahlhut MW, Hann HL, London WT. Hepatogastroenterology; 1988 Feb 01; 35(1):1-4. PubMed ID: 2452122 [Abstract] [Full Text] [Related]
37. The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance. Huo TI, Hsia CY, Chu CJ, Huang YH, Lui WY, Wu JC, Lee PC, Chi CW, Lee SD. J Surg Oncol; 2007 Jun 15; 95(8):645-51. PubMed ID: 17530668 [Abstract] [Full Text] [Related]
38. Assessment of alpha-fetoprotein in chronic HBsAg carriers and in HBsAg negative cirrhosis of the liver. Stránský J, Zichová M, Vodák M. Sb Lek; 1993 Jun 15; 94(4):311-5. PubMed ID: 7527585 [Abstract] [Full Text] [Related]
39. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma. Soga K, Watanabe T, Aikawa K, Toshima M, Shibasaki K, Aoyagi Y. Hepatogastroenterology; 1998 Jun 15; 45(23):1737-41. PubMed ID: 9840138 [Abstract] [Full Text] [Related]